AdaptHealth (AHCO) Cost of Revenue (2019 - 2026)

AdaptHealth's Cost of Revenue history runs 8 years deep, the most recent figure standing at $708.3 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 7.74% year-over-year to $708.3 million in Q1 2026; TTM through Mar 2026 was $2.7 billion, a 3.24% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 2.16% from the prior year.
• Cost of Revenue grew to $708.3 million in Q1 2026 per AHCO's latest filing, from $674.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $708.3 million in Q1 2026 and bottomed at $536.6 million in Q4 2022.
• The 5-year median for Cost of Revenue is $646.7 million (2022), against an average of $640.6 million.
• Biggest YoY gain for Cost of Revenue was 50.52% in 2022; the steepest drop was 9.29% in 2022.
• Year by year, Cost of Revenue stood at $536.6 million in 2022, then increased by 3.2% to $553.8 million in 2023, then climbed by 19.97% to $664.4 million in 2024, then grew by 1.46% to $674.1 million in 2025, then increased by 5.07% to $708.3 million in 2026.
• Per Business Quant, the three latest AHCO Cost of Revenue figures stand at $708.3 million (Q1 2026), $674.1 million (Q4 2025), and $658.4 million (Q3 2025).